{
    "clinical_study": {
        "@rank": "28393", 
        "arm_group": [
            {
                "arm_group_label": "Moxifloxacin", 
                "arm_group_type": "Active Comparator", 
                "description": "single oral administration of 400mg of moxifloxacin"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "single oral administration of 400mg of placebo"
            }
        ], 
        "brief_summary": {
            "textblock": "The Effect of Ethnic on Moxifloxacin Induced QT Interval Prolongation in Korean and Japanese\n      Healthy Subjects"
        }, 
        "brief_title": "The Effect of Ethnic on Moxifloxacin Induced QT Interval Prolongation in Korean and Japanese Healthy Subjects", 
        "completion_date": {
            "#text": "January 2013", 
            "@type": "Actual"
        }, 
        "condition": "Healthy", 
        "detailed_description": {
            "textblock": "The purpose of this study is to explore the ethnic and gender difference in the Moxifloxacin\n      induced QT interval prolongation between Japanese and Korean subjects."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        - 1) Subjects in Japan and Korea deemed healthy as determined by no clinically significant\n        deviation from normal in medical history, physical examination, ECGs, or clinical\n        laboratory determinations.\n\n        2) Body Mass Index (BMI) of 17.6 to 26.4 kg/m2, BMI = weight (kg)/ [height (m)]2.\n\n        Exclusion Criteria:\n\n          -  1) Evidence of organ dysfunction or any clinically significant deviation from normal\n             in physical examination, vital signs, ECG or clinical laboratory determinations\n             beyond what is consistent with the target population.\n\n             2) Any of the following on 12-lead ECG prior to study drug administration, confirmed\n             by repeat.\n\n          -  Heart rate \u2264 45 bpmmsec or Heart rate \u2265 100 bpmmsec\n\n          -  PR \u2265 210 msec\n\n          -  QRS \u2265 120 msec\n\n          -  QT \u2265 500 msec\n\n          -  QTcF: male \u2265 450 msec, female \u2265470msec\n\n          -  Iincomplete right bundle branch block\n\n          -  Marked Sinus Arrhythmia\n\n          -  Wondering pacemaker\n\n          -  Atrial rhythm"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "35 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "June 9, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01876316", 
            "org_study_id": "12-166"
        }, 
        "intervention": [
            {
                "arm_group_label": "Moxifloxacin", 
                "description": "single oral administration of 400mg of moxifloxacin", 
                "intervention_name": "Moxifloxacin", 
                "intervention_type": "Drug", 
                "other_name": "Avelox"
            }, 
            {
                "arm_group_label": "Placebo", 
                "description": "single oral administration of 400mg of placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug", 
                "other_name": "Lactose"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Moxifloxacin", 
                "Norgestimate, ethinyl estradiol drug combination"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Moxifloxacin", 
            "QT interval prolongation", 
            "Korean", 
            "Japanese"
        ], 
        "lastchanged_date": "June 11, 2013", 
        "number_of_arms": "2", 
        "official_title": "A Randomized, Double-blind, Placebo-controlled, Two-way Crossover Trial to Compare Moxifloxacin Induced QT Interval Prolongation in Japanese and Korean Healthy Subjects", 
        "overall_official": {
            "affiliation": "Inje University", 
            "last_name": "Jae-Gook Shin, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "South Korea: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "12 point of ECG measurements according to the interventions", 
            "measure": "double delta QTcF", 
            "safety_issue": "Yes", 
            "time_frame": "up to 24 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01876316"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Inje University", 
            "investigator_full_name": "Jae-Gook Shin", 
            "investigator_title": "Department of Pharmacology and Pharmacogenomics Research Center", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "double delta QTcI, double delta QTcSS", 
            "safety_issue": "Yes", 
            "time_frame": "up to 24 hours"
        }, 
        "source": "Inje University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Inje University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Pharmacokinetics/Dynamics Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Health Services Research", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}